|
NCCN Guidelines® Insights - Rectal Cancer, Version 6.2020 |
1.00 |
07/10/2020 - 12:00am to 07/10/2021 - 12:00am |
|
NCCN Guidelines® Insights - Survivorship, Version 2.2020 |
1.00 |
08/10/2020 - 12:00am to 08/10/2021 - 12:00am |
|
NCCN Guidelines® Insights - Uveal Melanoma, Version 1.2019 |
1.00 |
02/10/2020 - 12:00am to 02/10/2021 - 12:00am |
|
NCCN Pharmacy Updates: Assessment and Management of CAR T-Cell Related Toxicities |
1.00 |
06/08/2020 - 12:00am to 11/01/2020 - 12:00am |
|
NCCN Pharmacy Updates: Emerging Strategies in the Treatment of Venous Thromboembolism |
1.00 |
06/08/2020 - 12:00am to 03/07/2021 - 12:00am |
|
NCCN Pharmacy Updates: Establishing a Place in Therapy for Biosimilars in Oncology |
1.00 |
06/08/2020 - 12:00am to 01/10/2021 - 12:00am |
|
NCCN Pharmacy Updates: Novel Treatments for Neuroendocrine Tumors |
1.00 |
06/08/2020 - 12:00am to 12/06/2020 - 12:00am |
|
NCCN Pharmacy Updates: Treatment Advances for Pediatric B-Cell Non-Hodgkin's Lymphomas |
1.00 |
06/08/2020 - 12:00am to 02/07/2021 - 12:00am |
|
New Approaches to Multiple Myeloma Therapy |
1.00 |
05/12/2020 - 12:00am to 05/12/2021 - 12:00am |
|
New Targeted Therapies for Non-Small Cell Lung Cancer |
1.25 |
12/17/2019 - 12:00am to 12/17/2020 - 12:00am |
|
New Therapeutic Developments in Urothelial Cancer: Clinical Trial Evidence and Expert Guidance |
1.75 |
07/02/2020 - 12:00am to 07/02/2021 - 12:00am |
|
Novel and Emerging Treatment Strategies for Acute Myeloid Leukemia |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Optimizing the Management of Endometrial Cancer |
0.50 |
07/01/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Optimizing Treatment for Head and Neck Cancers |
1.50 |
07/09/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Practical Application of Immuno-Oncology in Renal Cell Carcinoma |
1.75 |
03/17/2020 - 12:00am to 03/17/2021 - 12:00am |
Facebook
Twitter
LinkedIn
Forward